Chapter 10
Reproductive and
Growth Hormones

Testosterone

Learning Goal: Describe testosterone's production, its regulatory axis, and its metabolic roles beyond reproduction.

1Testosterone's Source and Regulatory Axis

Testosterone, the primary androgen (male-associated steroid hormone), is produced predominantly by the testes in men and, in much smaller amounts, by the ovaries and adrenal glands in women. Its production follows the same axis template established in Lesson 9.2: the hypothalamus releases GnRH (gonadotropin-releasing hormone), which signals the pituitary to release LH (luteinising hormone), which signals the testes (or, in women, the ovaries) to produce testosterone — the hypothalamic-pituitary-gonadal (HPG) axis, regulated by the same negative-feedback logic already familiar from the HPT and HPA axes.

2Testosterone's Metabolic Roles

Beyond its reproductive functions, testosterone has genuine, well-documented metabolic roles directly relevant to this volume: it promotes muscle protein synthesis (extending Lesson 6.7's material with a hormonal driver not previously covered), supports bone mineral density, influences fat distribution (Lesson 10.8), and supports red blood cell production via effects on erythropoietin signalling. These effects explain why testosterone deficiency, in either sex, is associated with reduced muscle mass, reduced bone density, and altered body composition, not merely reduced reproductive function.

3Age-Related Decline

Testosterone levels in men typically peak in early adulthood and decline gradually with age, a normal process sometimes termed andropause, though the decline is generally more gradual and variable than the more clearly demarcated menopausal transition covered in Lesson 10.2's material on oestrogen. Clinically significant testosterone deficiency (hypogonadism), distinct from ordinary age-related decline, is a recognised medical condition requiring physician diagnosis via appropriate blood testing and clinical evaluation, not something inferred from symptoms or age alone.

4Testosterone in Women

Though present at roughly one-tenth to one-twentieth the concentration found in men, testosterone plays a genuine, non-trivial role in women's physiology too — contributing to libido, bone density, muscle mass and mood — and conditions involving testosterone excess in women (most notably polycystic ovary syndrome, PCOS, covered further in Lesson 10.4) or testosterone deficiency both carry genuine clinical significance, underscoring that this hormone, despite its "male hormone" popular reputation, is relevant to comprehensive nutrition practice across all clients, not only male clients focused on muscle-building goals.

5Sex Hormone-Binding Globulin (SHBG)

Much like the thyroid-binding globulin covered in Lesson 9.3, testosterone circulates in blood mostly bound to a carrier protein — sex hormone-binding globulin (SHBG) — with only the small free (and a further loosely bound, "bioavailable") fraction actually able to exert biological effects at target tissues. SHBG levels themselves are influenced by several factors, including insulin (higher insulin, as in insulin resistance, tends to suppress SHBG production, connecting directly to Chapter 7's material) and thyroid status — meaning total testosterone measurements alone, much like total T4 in Lesson 9.3, can be an incomplete picture, and free or bioavailable testosterone is often the more clinically informative measurement, particularly in the context of conditions like PCOS (Lesson 10.4) where insulin resistance and altered SHBG frequently co-occur.

6Testosterone, vegetarian diets and Indian men

A persistent belief in Indian gyms is that vegetarian eating lowers testosterone and prevents muscle gain. The evidence does not support it: where energy intake, protein and body fat are adequate, vegetarian and non-vegetarian men show broadly similar testosterone. What vegetarian Indian diets genuinely do risk is lower zinc intake, since the best sources are shellfish and red meat while plant zinc is bound by phytates — and zinc deficiency does affect testosterone. That is a specific, testable nutrient issue, not a verdict on vegetarian eating.

The practical response is soaked and sprouted legumes, fermented preparations such as idli and dhokla which reduce phytate, and pumpkin seeds, cashews, chana and dairy in the daily pattern. Far more consequential than any of this, though, are the factors men rarely connect to hormones: five hours of sleep, a chronic energy deficit, very low body fat, and untreated chronic stress all suppress testosterone more reliably than diet composition does. Where symptoms suggest genuinely low testosterone — persistent fatigue, loss of libido, absent morning erections — that is a blood test and a doctor, not a supplement stack.

Oestrogen

Learning Goal: Describe oestrogen's production, its metabolic roles, and the physiological consequences of its decline at menopause.

1Oestrogen's Source and the Menstrual Cycle Context

Oestrogen (more precisely, a family of related hormones, the most physiologically significant being oestradiol during reproductive years) is produced predominantly by the ovaries, following the same HPG axis template as testosterone, with the added complexity that oestrogen production rises and falls cyclically across the menstrual cycle (detailed fully in Lesson 10.4) rather than remaining comparatively steady the way testosterone typically does in men.

2Oestrogen's Metabolic and Protective Roles

Beyond its reproductive functions, oestrogen has several well-documented protective metabolic effects: it supports bone density by restraining bone resorption (the breakdown side of ongoing bone remodelling), supports favourable blood lipid profiles (generally associated with higher HDL and lower LDL cholesterol during reproductive years, connecting to Lesson 5.8's lipid panel material), and appears to support insulin sensitivity, contributing to the generally lower rates of insulin resistance and type 2 diabetes observed in premenopausal women compared with age-matched men.

3Menopause: The Sharp Decline

Menopause — marked by the cessation of menstrual cycles, typically occurring in the late 40s to early 50s — involves a comparatively sharp, rather than gradual, decline in ovarian oestrogen production, in contrast to testosterone's more gradual age-related decline in men (Lesson 10.1). This sharper transition is associated with a correspondingly more concentrated cluster of physiological changes: accelerated bone density loss (directly reflecting oestrogen's restraint on bone resorption being withdrawn), a measurable shift toward a less favourable lipid profile, a documented tendency toward increased visceral (rather than the more oestrogen-associated subcutaneous, hip/thigh) fat distribution (Lesson 10.8), and reduced insulin sensitivity.

4Nutritional Implications of the Menopausal Transition

The cluster of changes described above gives menopause genuine, mechanistically grounded nutritional relevance, distinct from simply "ageing in general": adequate calcium and vitamin D intake become particularly important given accelerated bone loss risk (connecting forward to Volume 7's more detailed bone-health material), attention to cardiovascular risk factors becomes more pressing given the lipid profile shift, and body composition changes (particularly the shift toward more visceral fat) may warrant adjusted body-composition-focused strategies distinct from those appropriate during reproductive years — a nutrition professional working with perimenopausal or postmenopausal clients should recognise this as a genuine physiological transition with specific, evidence-based implications, not simply advise "eat less" in response to reported weight or body-composition changes during this period.

5Oestrogen's Different Forms Across the Lifespan

"Oestrogen" is more precisely a family of related hormones whose relative dominance shifts across life stages: oestradiol, the most potent and physiologically dominant form during reproductive years (the form this lesson's material has focused on), oestrone, which becomes relatively more significant after menopause (produced partly by conversion from adrenal precursors in adipose tissue, connecting to Lesson 5.4's material on adipose tissue as an endocrine organ), and oestriol, significant chiefly during pregnancy. This distinction matters clinically because postmenopausal oestrogen, though substantially reduced compared with reproductive-age levels, is not literally zero — the oestrone produced via adipose tissue conversion means, notably, that body fat percentage can modestly influence postmenopausal oestrogen status, one of several reasons extremely low body fat is not straightforwardly "better" for hormonal health at every life stage, echoing this chapter's broader energy-availability theme (Lesson 10.9).

Progesterone

Learning Goal: Describe progesterone's production, its cyclical pattern, and its metabolic effects during the luteal phase.

1Progesterone's Source and Cyclical Pattern

Progesterone is produced predominantly by the corpus luteum — a temporary hormone-producing structure that forms from the ovarian follicle after ovulation (detailed fully in Lesson 10.4's cycle-phase material) — meaning progesterone is essentially undetectable during the first half of the menstrual cycle and rises sharply only after ovulation occurs, a fundamentally different pattern from oestrogen's more continuous, if fluctuating, presence throughout the cycle.

2Progesterone's Metabolic Effects

During the luteal phase (the second half of the cycle, when progesterone is elevated), several measurable metabolic shifts occur: a modest increase in resting metabolic rate (typically a small but measurable rise, on the order of a few percent), a mild increase in body temperature (the basis for temperature-based ovulation tracking methods), and, for many though not all individuals, increased appetite and specific food cravings — connecting to Lesson 8.9's hedonic eating material, since progesterone's luteal-phase appetite effects appear to interact with, rather than simply mimic, the reward-system mechanisms covered there.

3Progesterone and Fluid Balance

Progesterone also influences fluid balance, with many individuals experiencing mild fluid retention during the luteal phase — a genuine physiological effect, not merely a subjective impression, though its magnitude varies considerably between individuals. This is a useful, practical point for nutrition professionals: a client reporting a small, cyclical weight fluctuation aligned with her luteal phase is very plausibly observing genuine fluid-related change rather than actual fat mass change, and interpreting a scale reading without cycle-phase context can lead to inaccurate conclusions about genuine progress or setbacks.

4Progesterone's Interaction With Oestrogen

Progesterone and oestrogen's effects are best understood as a coordinated, phase-dependent pair rather than two independent, unrelated hormones — the follicular phase's oestrogen-dominant environment supports one set of physiological priorities (egg maturation, uterine lining growth), while the luteal phase's progesterone-dominant environment supports a different set (maintaining a potential pregnancy-ready uterine environment, along with the metabolic and appetite shifts described above). This coordinated, alternating pattern is the mechanistic foundation Lesson 10.4 builds on directly when discussing nutritional strategy across the full menstrual cycle.

5Progesterone, Mood and Premenstrual Symptoms

Beyond its metabolic and fluid-balance effects, progesterone (and its interaction with fluctuating oestrogen) is implicated in premenstrual symptoms experienced by many individuals in the days before menstruation — commonly including mood changes, irritability and, for a smaller subset, more severe premenstrual dysphoric disorder (PMDD), a clinically recognised condition distinct from ordinary premenstrual symptoms in severity and functional impact. The precise mechanism connecting normal hormonal fluctuation to these mood effects remains an active area of research, involving progesterone's metabolites' interaction with brain neurotransmitter systems, but the practical takeaway for nutrition professionals is similar to this lesson's earlier point about physical symptoms: premenstrual mood changes reported by a client are very plausibly a genuine, hormonally mediated phenomenon worth acknowledging directly rather than dismissing, while more severe or functionally impairing symptoms (potential PMDD) warrant medical referral rather than nutrition-only management.

6The luteal phase on an Indian diet

Progesterone rises in the second half of the cycle and brings a small increase in resting expenditure, a rise in appetite, a shift toward carbohydrate preference, higher body temperature, and for many women fluid retention and slower gut transit. In practice this arrives as premenstrual cravings for exactly the foods an Indian evening supplies most readily — mithai, namkeen, biscuits with chai — and as a scale reading two kilograms higher that has nothing to do with fat.

Two things help more than restriction. First, expect it: a woman who knows her appetite rises in the luteal phase and that her weight fluctuates with water is far less likely to conclude her diet has failed and abandon it. Comparing weight at the same point across cycles rather than week to week removes the noise. Second, meet the appetite with protein and fibre rather than fighting it — curd, chana, paneer, fruit — which blunts the craving more effectively than willpower. And menstrual blood loss is a continuing iron drain, which is why iron status deserves checking in Indian women whose diets are largely plant-based.

The Menstrual Cycle and Nutrition

Learning Goal: Describe the menstrual cycle's hormonal phases in sequence and their practical nutritional implications.

1The Four Phases in Sequence

The cycle begins with menstruation (shedding of the uterine lining, triggered by the sharp fall in oestrogen and progesterone at the end of the previous cycle if pregnancy did not occur), followed by the follicular phase (rising oestrogen as an ovarian follicle matures, Lesson 10.2), a brief ovulation event (a sharp LH surge triggering release of the mature egg), and the luteal phase (progesterone rising from the corpus luteum, Lesson 10.3, alongside continued but declining oestrogen). If pregnancy does not occur, the corpus luteum degrades, progesterone and oestrogen fall sharply, and the cycle begins again with menstruation — a genuinely cyclical, self-repeating hormonal sequence typically spanning around 28 days, though normal individual variation in total cycle length is considerable.

2Iron Considerations During Menstruation

Menstrual blood loss represents a genuine, recurring source of iron loss specific to menstruating individuals, connecting directly to Lesson 2.10's iron absorption material — this is part of why iron requirements are meaningfully higher for menstruating women than for men or postmenopausal women, and why iron-deficiency anaemia is disproportionately common in this population specifically. A nutrition professional working with menstruating clients, particularly those with heavier-than-typical menstrual flow, should consider iron status and iron-rich or iron-fortified food intake as a genuinely relevant, mechanistically grounded consideration, not merely a generic supplement recommendation applied without cause.

3Cycle-Phase-Aware Nutrition: What the Evidence Actually Supports

Building directly on Lesson 10.3's material, the luteal phase's modestly increased metabolic rate and appetite are genuine, but the evidence does not support dramatically different macronutrient prescriptions for each cycle phase for most people — the more evidence-supported, practically useful application of cycle awareness is contextual interpretation (recognising luteal-phase cravings, fluid retention and appetite shifts as expected and hormonally driven, per Lesson 10.3) rather than prescriptive phase-specific dieting protocols, many of which extend beyond what current research firmly establishes. This is a useful area for calibrated, evidence-proportionate guidance: acknowledging genuine cyclical physiology without overselling elaborate phase-based nutrition programmes not yet strongly supported by robust trial evidence.

4PCOS: A Common Cycle-Disrupting Condition

Polycystic ovary syndrome (PCOS), briefly previewed in Lesson 10.1, is a common endocrine condition, frequently associated with irregular or absent ovulation, elevated androgens (including testosterone), and, importantly for this volume's broader themes, a strong association with insulin resistance (Lesson 7.7) — indeed, insulin resistance is now understood to play a central mechanistic role in PCOS for many affected individuals, with weight management and insulin-sensitivity-focused nutrition strategies forming an evidence-based component of management alongside medical treatment. This connection — a reproductive hormone condition with insulin resistance as a central mechanistic driver — is a clear, concrete illustration of why this volume treats metabolic and reproductive hormone systems as genuinely interconnected rather than separate topics.

5PCOS in India, and what nutrition can and cannot do

Polycystic ovary syndrome is common among Indian women, and prevalence estimates vary widely — roughly 4% to over 20% depending on the diagnostic criteria used and the population studied — which itself tells you the condition is under-standardised rather than rare. It commonly presents with irregular or absent periods, signs of excess androgens such as acne or unwanted hair growth, and frequently with insulin resistance. That last link is the one nutrition acts on, and it is why PCOS appears in a metabolism volume at all.

What is genuinely supported is unglamorous: improving insulin sensitivity through resistance training and regular activity, a modest and sustainable energy deficit where excess weight is present, adequate protein, and attention to sleep. Even small weight reductions can restore ovulation in some women. What is not supported is the long list of teas, seed protocols and detoxes marketed for PCOS in India. And the diagnosis itself, along with any medication, belongs with a gynaecologist or endocrinologist — irregular periods have several possible causes and assuming PCOS without assessment can delay finding the real one.

Growth Hormone

Learning Goal: Describe growth hormone's production, its regulation, and its direct and indirect metabolic effects.

1Growth Hormone's Source and Regulation

Growth hormone (GH) is produced by the anterior pituitary (Lesson 9.2's anterior/posterior distinction directly relevant here), released in response to GHRH (growth hormone-releasing hormone) from the hypothalamus and suppressed by a separate hypothalamic hormone, somatostatin — a slightly more complex regulatory picture than the single-releasing-hormone pattern seen for TSH and ACTH, since GH release is governed by both a stimulating and an independently acting suppressing signal.

2Growth Hormone's Pulsatile Release Pattern

Unlike many hormones covered in this volume that maintain relatively steady circulating levels, GH is released in sharp, intermittent pulses rather than continuously, with the largest and most reliable pulses occurring during deep sleep — a pattern directly connecting to Lesson 8.3's sleep-hormone material and previewing Chapter 12's fuller circadian treatment, and underscoring why adequate sleep quality is not merely relevant to appetite hormones but to growth hormone's normal release pattern as well.

3Growth Hormone's Direct Metabolic Effects

Independent of its IGF-1-mediated growth effects, GH has several direct metabolic actions: it promotes lipolysis (mobilising stored fat for fuel, working in a broadly similar direction to cortisol's acute effects, Lesson 9.6, though via an entirely separate mechanism), and it has a modest glucose-raising, insulin-antagonising effect, meaning very high GH levels (as seen in the rare condition of GH-secreting pituitary tumours) can produce a form of insulin resistance and, in some cases, secondary diabetes — a clinically important, if uncommon, illustration that growth-promoting and glucose-regulating hormone systems are not fully independent of one another.

4Exercise, Sleep and Growth Hormone Release

Both resistance and high-intensity exercise, and deep sleep specifically, are well-documented, genuine triggers of increased GH pulse release, connecting directly to Lesson 7.10's exercise material and Lesson 8.3's sleep-ghrelin material — meaning both training and sleep quality are relevant, evidence-based levers for supporting normal GH release patterns, a mechanistic thread that recurs when Lesson 10.7 examines GH's role in muscle growth specifically.

5Growth Hormone's Gradual Age-Related Decline

Similar in overall pattern to testosterone's gradual decline (Lesson 10.1), GH pulse amplitude and frequency decline gradually with age, a process sometimes termed somatopause — contributing, alongside declining sex hormones and reduced physical activity common with ageing, to the gradual loss of muscle mass and bone density often observed in older adults, though the relative contribution of each factor is difficult to fully separate given how commonly they decline together. This age-related GH decline is one reason resistance training and adequate protein intake become, if anything, more rather than less important for older adults specifically (a theme already established nutritionally in Lesson 6.6's protein-requirements material), since these interventions can help offset, though not fully reverse, some of the hormonal decline's downstream muscle and bone consequences.

6Growth hormone, sleep and the Indian schedule

The largest pulse of growth hormone release accompanies the first phase of deep slow-wave sleep, typically in the earlier part of the night. That places it directly in conflict with a common Indian pattern: dinner at 10, television or phone until midnight, and an alarm at 6 for a commute. Cutting the night short truncates precisely the window in which most of the day's growth hormone is released, and no supplement compensates for it.

Two structural factors deserve naming because they are rarely in the athlete's control. Shared sleeping space is normal in Indian housing, so a consistent, protected sleep window often requires a household conversation rather than an individual decision. And heat matters — sleeping in 32°C without cooling fragments sleep architecture measurably, which is a real seasonal effect across much of the country. Where those can be improved even partially, they do more for recovery and growth than the entire category of products sold for the purpose. The evening protein serving — milk, curd or paneer before bed — is a genuine and cheap contributor; a growth-hormone booster is not.

IGF-1

Learning Goal: Explain IGF-1's role as growth hormone's primary downstream mediator, and its nutritional regulation.

1IGF-1's Source and Relationship to Growth Hormone

Insulin-like growth factor 1 (IGF-1), named for its structural similarity to insulin, is produced predominantly by the liver in response to growth hormone stimulation — GH's binding to liver cell receptors triggers IGF-1 production and release, which then travels to target tissues throughout the body to mediate most of GH's actual growth-promoting cellular effects. This is precisely why IGF-1, rather than GH itself, is often the more clinically useful blood marker for assessing overall GH axis activity: because IGF-1 circulates at more stable levels (unlike GH's sharp pulses, Lesson 10.5) and its level directly reflects the cumulative, integrated GH signal over recent days rather than a single momentary pulse.

2IGF-1's Growth-Promoting Actions

IGF-1 promotes cell growth and proliferation across multiple tissues, most notably supporting linear bone growth during childhood and adolescence (working at growth plates, the cartilage regions responsible for increasing bone length before they close at the end of puberty) and, throughout life, supporting tissue repair and muscle protein synthesis — directly overlapping with, and complementing, the mTOR-pathway muscle protein synthesis mechanisms already covered in Lesson 6.7, giving IGF-1 a second, hormone-mediated route into the same downstream cellular growth machinery leucine activates nutritionally.

3Nutritional Regulation of IGF-1

Unlike growth hormone itself, whose release is governed chiefly by the hypothalamic and sleep/exercise factors covered in Lesson 10.5, IGF-1 production is directly, measurably sensitive to nutritional status — adequate total energy and, specifically, adequate protein intake support normal IGF-1 production, while sustained caloric restriction or inadequate protein intake measurably reduces circulating IGF-1, even when GH release itself is unaffected or even compensatorily increased. This creates a genuinely important, sometimes counterintuitive pattern during aggressive dieting: GH pulses may be normal or elevated, yet IGF-1 (the hormone actually doing most of the growth-promoting work) can still fall, because the liver's capacity to convert the GH signal into IGF-1 output is itself nutritionally dependent.

4Implications for Dieting and Training

This nutritional sensitivity of IGF-1 has direct practical relevance for clients pursuing simultaneous aggressive caloric restriction and muscle-building or strength goals: because IGF-1, not GH pulses alone, mediates much of the tissue-level growth-promoting effect relevant to muscle protein synthesis and repair, an overly aggressive deficit risks blunting IGF-1 output specifically, potentially undermining muscle retention and recovery capacity beyond what protein intake alone would predict — reinforcing, from yet another mechanistic angle, this volume's recurring theme (Lesson 8.10, Lesson 9.9) that moderate, well-designed deficits with adequate protein tend to outperform overly aggressive ones for body-composition-focused goals specifically, not only for hunger management.

5Why GH/IGF-1 Are Not Simply "More Is Better"

Despite GH's and IGF-1's genuinely beneficial roles in growth, repair and body composition within the normal range, research on very high, sustained GH/IGF-1 levels (as seen in acromegaly, a rare condition of GH-secreting pituitary tumours in adults, or with unsupervised supraphysiological GH/IGF-1 use) has identified genuine risks, including the insulin resistance mentioned in Lesson 10.5 and research interest in potential associations with certain cancer risk pathways at chronically elevated levels — an important reminder, echoed at multiple points across this chapter, that "more hormone" is not straightforwardly better once levels exceed the normal physiological range, and that legitimate medical use of GH (for diagnosed GH deficiency) is carefully dosed and monitored specifically to avoid these supraphysiological-range risks rather than simply maximising GH/IGF-1 levels.

Hormones and Muscle Growth

Learning Goal: Integrate testosterone, growth hormone and IGF-1 into a coordinated model of hormonal contributions to muscle growth, alongside Chapter 6's nutritional mechanisms.

1Testosterone's Contribution

Testosterone (Lesson 10.1) directly promotes muscle protein synthesis and appears to enhance satellite cell activity (specialised muscle stem cells that support muscle fibre repair and growth), contributing to testosterone's well-documented role in supporting greater muscle mass and strength gains — this is the primary mechanistic reason average sex differences in muscle mass and strength trajectories are observed between men and women, and why clinically low testosterone (in either sex) is associated with reduced ability to build and maintain muscle even with adequate training and nutrition.

2Growth Hormone's and IGF-1's Contribution

Building directly on Lessons 10.5–10.6, GH and (more directly) IGF-1 support muscle protein synthesis and satellite cell activity through a mechanistically distinct pathway from testosterone, converging on some of the same downstream cellular growth machinery (the mTOR pathway, Lesson 6.7) that leucine and mechanical loading also activate nutritionally. This convergence — multiple distinct upstream signals feeding into a shared downstream growth pathway — is a recurring pattern in physiology worth recognising explicitly: it means several genuinely independent levers (adequate protein/leucine, resistance training, adequate sleep supporting GH pulses, adequate energy intake supporting IGF-1) can each meaningfully support the same ultimate outcome, rather than there being one single dominant lever to the exclusion of all others.

3Why Training and Nutrition Remain the Dominant, Practical Levers

Despite these genuine hormonal contributions, it is important to correctly weight their relative practical significance for most people: within the normal physiological range (as opposed to clinically low testosterone, GH deficiency, or pharmacological hormone administration), resistance training stimulus and adequate protein/energy intake remain the dominant, most controllable and most evidence-supported levers for muscle growth in the general population — normal-range hormonal variation between individuals explains comparatively little of the variation in muscle-building outcomes compared with training and nutritional consistency, a distinction Lesson 10.10 returns to directly when addressing hormone-optimisation marketing claims.

4When Hormonal Factors Become the Primary Limiting Factor

Hormonal factors become the primary, rather than secondary, limiting factor specifically in cases of diagnosed clinical deficiency (hypogonadism, GH deficiency) or during unusually aggressive, prolonged caloric restriction sufficient to meaningfully suppress testosterone and IGF-1 output (previewing Lesson 10.9's energy availability material) — in these specific circumstances, addressing the underlying hormonal issue (medically, or via adequate energy availability) becomes genuinely necessary before training and nutrition adjustments alone can be expected to produce normal results, a meaningful exception to the general "training and nutrition dominate" principle stated above, not a contradiction of it.

5Building muscle on Indian vegetarian protein

Hormones set the ceiling; protein supplies the material, and this is where Indian vegetarian athletes most often fall short without realising. The arithmetic is unforgiving: a household bowl of dal delivers roughly 4–6 g of protein, not the 15 g the dry-weight table suggests, and a plate of rice with that dal is a carbohydrate meal wearing a protein label. Two rotis add about 6 g. A day built on that pattern reaches perhaps 45 g against a requirement two or three times higher.

The correction uses food already in the kitchen. Soya chunks at roughly ₹3 per 10 g of protein are the cheapest complete protein available in India and the single most effective addition. A dairy serving at every meal — 200 g curd, a glass of milk, 100 g paneer — supplies leucine in the per-meal amounts that actually trigger growth. Roasted chana in the afternoon adds 20 g for ₹20. None of this requires a powder, and all of it is available in a kirana shop. Distribution across three or four meals beats concentrating everything into dinner.

Hormones and Body-Fat Distribution

Learning Goal: Explain how sex hormones influence characteristic patterns of body-fat distribution, and how these patterns shift with hormonal change.

1Oestrogen and the "Gynoid" Pattern

Higher oestrogen levels, characteristic of the reproductive years in women, are associated with a fat distribution pattern sometimes termed gynoid — preferential storage in the hips, thighs and buttocks (subcutaneous fat specifically) rather than the abdomen. This pattern is thought to reflect, at least partly, an evolutionary function related to fat reserves supporting potential pregnancy and lactation, and is generally considered metabolically more favourable than the alternative pattern described next, consistent with subcutaneous fat's generally less inflammatory profile compared with visceral fat (Lesson 5.9).

2Testosterone/Lower-Oestrogen and the "Android" Pattern

Higher testosterone relative to oestrogen — characteristic of men generally, and of women after menopause as oestrogen declines (Lesson 10.2) — is associated with a fat distribution pattern sometimes termed android: preferential storage in the abdomen (a combination of both subcutaneous and, more significantly, visceral fat, Lesson 5.9). This pattern is associated with comparatively higher metabolic risk than the gynoid pattern, directly connecting to Chapter 7's visceral-fat-insulin-resistance material and helping explain average sex differences in metabolic disease risk profiles observed in research, alongside the many other contributing factors already covered throughout this volume.

3Why Fat Distribution Shifts Across Life Stages

These patterns are not fixed for life — they shift measurably as the underlying hormonal balance shifts, most notably at menopause, when declining oestrogen relative to testosterone commonly produces a measurable shift from the gynoid toward the android pattern (already introduced in Lesson 10.2), even without necessarily any change in total body weight or overall caloric balance. This is a genuinely important point for nutrition professionals working with perimenopausal and postmenopausal clients: a shift in where fat is stored, without a corresponding shift in total weight, reflects real hormonal change, not necessarily any change in dietary adherence or effort.

4Practical Implications

Understanding hormone-driven fat distribution patterns helps a nutrition professional set appropriate, evidence-grounded expectations: body-composition changes at menopause, or in someone with a diagnosed hormonal condition affecting the testosterone/oestrogen balance, may not respond to the same dietary and exercise approaches as effectively, or in the same distribution pattern, as they did earlier in life — not because the approach is wrong, but because the underlying hormonal instructions for where fat is preferentially stored and mobilised have genuinely changed. This does not mean body composition becomes uncontrollable at these life stages, but it does mean expectations and strategy should account for the real physiological shift rather than assuming identical approaches will produce identical distribution outcomes across every life stage.

5Fat Distribution Changes During Pregnancy

Pregnancy involves its own distinct, temporary shift in fat distribution and storage, driven by a substantially altered hormonal environment (rising oestriol, progesterone, and other pregnancy-specific hormones not covered in detail in this general chapter) — a genuinely different physiological context from either the gynoid or android patterns described above, reflecting the specific metabolic demands of supporting fetal development and preparing for lactation rather than either reproductive-cycling or ageing-related hormonal patterns. This is a useful reminder that this lesson's two-pattern framework (gynoid/android) describes the two most commonly discussed patterns relevant to general nutrition practice, not an exhaustive account of every hormonally influenced fat-distribution state the body can enter — pregnancy nutrition specifically involves additional, distinct considerations covered more fully in later volumes on life-stage nutrition.

6Where South Asians store fat, and why it matters

Sex hormones influence where fat is deposited — broadly hip and thigh storage under oestrogen, abdominal storage where androgens dominate or after menopause. Layered on top of that is a population difference that matters clinically: South Asians tend to store proportionally more fat viscerally, around the organs, at any given body weight. Two people of identical BMI, one South Asian and one European, can carry meaningfully different metabolic risk.

The practical consequence for anyone advising Indian clients is to stop treating the scale as the primary measure. Waist circumference, taken with a tape at a fixed point, captures the risk that matters and does so at thresholds lower than international guidance — around 90 cm for men and 80 cm for women. A woman after menopause will often notice fat redistributing toward the abdomen without her weight changing at all; that is a hormonal shift rather than a dietary failure, and framing it correctly saves a great deal of unnecessary self-blame.

Energy Availability and Reproductive Health

Learning Goal: Define energy availability, distinguish it from simple caloric deficit, and explain its consequences for reproductive and overall hormonal health.

1Defining Energy Availability

Energy availability is calculated as dietary energy intake minus exercise energy expenditure, then expressed relative to fat-free mass (typically as kcal per kg of fat-free mass per day) — a genuinely different concept from overall caloric balance (intake versus total expenditure including exercise), since two people with identical overall caloric balance could have very different energy availability if one exercises considerably more than the other. This distinction matters because research indicates it is specifically low energy availability, not caloric deficit or exercise volume in isolation, that most directly predicts the reproductive and hormonal consequences covered in this lesson.

2Low Energy Availability's Hormonal Consequences

Sustained low energy availability triggers a coordinated suppression of the HPG axis (Lesson 10.1) — reduced GnRH pulsatility leads to reduced LH and FSH, which in turn reduces oestrogen (in women) or testosterone (in men) production, alongside suppressed thyroid function (extending Lesson 9.9's diet-related T3 adaptation material to a more severe end of the same underlying spectrum) and elevated cortisol. This is the body's evolved response to perceived severe energy scarcity, functionally similar in logic to leptin's reproductive-suppressing effect at very low levels (briefly noted in Lesson 8.2) — deprioritising energy-costly reproductive function when the body perceives inadequate energy availability to support it safely.

3Relative Energy Deficiency in Sport (RED-S)

The clinical syndrome resulting from sustained low energy availability, particularly well-documented in athletic populations with high training volumes and, sometimes, deliberately restricted intake, is termed Relative Energy Deficiency in Sport (RED-S) — encompassing menstrual dysfunction (irregular or absent periods) in women, reduced testosterone in men, impaired bone density (reflecting reduced oestrogen's or testosterone's bone-protective roles, Lessons 10.1–10.2), impaired immune function, and, notably, impaired rather than enhanced athletic performance despite the training volume that often accompanies it — a genuinely important, evidence-based counterpoint to any assumption that more training and a larger deficit reliably produce better athletic or body-composition outcomes.

4Why Missed Periods Are a Warning Sign, Not a Neutral Side Effect

A particularly important, practically actionable point from this lesson: menstrual irregularity or absence (amenorrhea) in an athletic or dieting client should never be dismissed as a convenient, neutral, or even desirable side effect of intensive training or dieting — it is a genuine, medically significant warning sign of low energy availability with real consequences (particularly for bone health, given oestrogen's protective role established in Lesson 10.2, and given that bone density built during younger years is difficult to fully recover later in life). A nutrition professional encountering a client reporting missed periods in the context of heavy training or dieting has a clear, evidence-based basis for recommending increased energy availability and appropriate medical evaluation, not for treating the missed periods as an unimportant footnote to otherwise successful training or dieting progress.

5RED-S Is Under-Recognised in Men

Because RED-S's most easily observed marker — menstrual dysfunction — applies specifically to women, the condition has historically been comparatively under-recognised and under-researched in men, despite men experiencing the same underlying HPG axis suppression, reduced testosterone, impaired bone density and performance consequences from sustained low energy availability. Men lack an equivalently visible, easily self-monitored warning sign analogous to a missed period, meaning low energy availability in male athletes may go unrecognised for longer, often surfacing instead as unexplained performance plateaus, recurrent injury (including stress fractures reflecting impaired bone density), or persistent fatigue — a genuinely important awareness point for nutrition professionals working with male athletes specifically, who should not assume RED-S risk applies only to their female clients.

6Energy availability in Indian athletes and dancers

Low energy availability — chronically eating too little for the training being done — suppresses reproductive hormones, and the clearest sign in women is menstrual disturbance. In India this appears most often in groups where leanness is expected and eating is casual: classical dance students carrying heavy rehearsal loads, distance runners, gym-goers chasing rapid fat loss, and adolescent athletes in residential academies where mess food and training demand are poorly matched.

The point to state without hedging is that losing periods is never a normal training adaptation. It is a medical finding, associated with reduced bone density and stress fractures, and it warrants referral to a doctor rather than a nutritional adjustment made alone. In men the presentation is quieter — reduced libido, persistent fatigue, stalled progress — and is missed more often for exactly that reason. The correction is more food and adequate carbohydrate rather than more discipline, which is usually the opposite of what the athlete expects to hear.

Natural Hormone Optimisation versus Marketing Claims

Learning Goal: Critically evaluate popular "hormone optimisation" claims against this chapter's mechanistic evidence base.

1What Genuinely Supports Normal Hormonal Function

This chapter has already established several genuinely evidence-supported levers: adequate total energy and protein intake (supporting IGF-1 and avoiding the RED-S consequences of Lesson 10.9), adequate sleep (supporting GH pulses and normal cortisol rhythm), regular resistance and appropriate-volume exercise (supporting GH release and, per Lesson 10.7, muscle-building hormonal signalling), adequate iodine and selenium (supporting thyroid function, Lesson 9.5), and appropriate body composition (avoiding both excess visceral fat's hormonal consequences and RED-S's under-fuelling consequences). These are genuine, well-supported "hormone optimisation" strategies in the accurate sense — supporting normal physiological function within the normal range, not pushing hormone levels above what is normal or healthy.

2"Testosterone-Boosting" Supplement Claims

Numerous supplements are marketed with claims of substantially raising testosterone in people without a diagnosed deficiency — the evidence for most such supplements (various herbal extracts frequently marketed this way) showing a meaningful, clinically significant testosterone increase in people with already-normal testosterone is generally weak or absent, in contrast to the well-established, larger effects of adequate sleep, appropriate training, and avoiding severe caloric restriction or excess body fat, all covered earlier in this chapter. A useful evaluative principle for clients asking about such supplements: if a specific product claim were genuinely well-supported and produced a clinically meaningful effect, it would generally already be reflected in mainstream clinical guidance for hypogonadism management, rather than existing primarily in supplement marketing material.

3Cortisol-Lowering and Adrenal Supplement Claims

Building directly on Lesson 9.10's "adrenal fatigue" material, supplements marketed specifically to "lower cortisol" or "support adrenal function" in people without a diagnosed cortisol-related medical condition generally lack strong evidence for producing meaningful, sustained hormonal change, in contrast to the well-established, larger effects of addressing the actual sources of chronic stress and improving sleep quality — genuine, if less easily monetised, interventions covered throughout Lesson 9.7's chronic stress material.

4A General Framework for Evaluating Hormone-Related Claims

A useful, transferable evaluative framework, applicable well beyond this specific chapter: ask whether a claimed intervention (a) addresses one of the genuinely evidence-supported levers this chapter has established (sleep, training, adequate nutrition, appropriate body composition), in which case it is likely legitimate though probably not novel or exclusive to the specific product being marketed; or (b) claims a specific supplement or product produces hormone changes exceeding what these established levers achieve, in which case the burden of evidence is considerably higher and should be scrutinised accordingly, particularly when the claim is not reflected in mainstream clinical or sports-medicine guidance. This framework, more than memorising individual product claims, equips a nutrition professional to evaluate whatever new "hormone optimisation" product or claim emerges next, since the underlying evaluative logic remains stable even as specific marketed products change.

5Ashwagandha, shilajit and the Indian supplement aisle

The Indian market carries an unusually large trade in products promising hormonal benefit: ashwagandha, shilajit, safed musli, testosterone boosters and assorted proprietary blends. The honest position on ashwagandha is that it has some reasonable evidence for effects on perceived stress and sleep quality, and much weaker evidence for the muscle and testosterone claims made in its marketing. Shilajit has very limited human evidence for the physique and hormonal claims attached to it, and product quality is highly variable, with contamination with heavy metals a documented concern in unregulated preparations.

The structural problem is that supplements in India are regulated as foods rather than as medicines, so the burden of proof before sale is low and label accuracy is inconsistent. The practical filter is the same as everywhere else in this programme: within-normal hormonal variation responds far more to sleep, adequate energy intake, body fat in a sensible range and consistent training than to any product on the shelf. Where a genuine hormonal disorder is suspected, that is a doctor and a blood test, not an ayurvedic proprietary blend.

Chapter Revision

Learning Goal: Consolidate reproductive and growth hormone physiology into one integrated model, from individual hormones through body composition to energy availability.

1Sex Hormones, Consolidated

Testosterone and oestrogen (Lessons 10.1–10.2), both governed by the HPG axis, each carry metabolic roles well beyond reproduction — muscle, bone, fat distribution, insulin sensitivity — meaning their decline (gradual for testosterone, sharper for oestrogen at menopause) produces measurable, mechanistically explicable body-composition and metabolic changes, not merely reproductive ones. Progesterone (Lesson 10.3) and the full menstrual cycle sequence (Lesson 10.4) add a genuinely cyclical dimension specific to reproductive-age women, with practical implications for iron status, appetite/craving interpretation, and scale-weight interpretation.

2Growth Hormone and IGF-1, Consolidated

Growth hormone (Lesson 10.5) and its primary downstream mediator IGF-1 (Lesson 10.6) illustrate a genuinely two-step hormonal relay, with IGF-1's direct nutritional sensitivity — unlike GH's chiefly sleep/exercise-driven regulation — providing a distinct, important mechanistic link between energy/protein adequacy and tissue-level growth and repair capacity, directly relevant to muscle-building outcomes during dieting (Lesson 10.7).

3Body Composition and the Energy Availability Threshold

Lesson 10.8's fat-distribution material and Lesson 10.9's energy availability material together establish that this chapter's hormones influence not just whether muscle is built or fat is lost, but where fat is stored and, at a more severe threshold, whether the reproductive and broader hormonal system continues functioning normally at all. RED-S represents the clearest, most severe endpoint of a spectrum this volume has traced from Lesson 8.10's dieting-hunger adaptation, through Lesson 9.9's diet-related T3 adaptation, to this chapter's full HPG axis suppression — progressively more severe hormonal consequences of progressively more severe or sustained energy deficits.

4A Worked Example Tying the Chapter Together

Consider a 26-year-old competitive triathlete reporting irregular periods for the past four months, a recent stress fracture, and frustration at a performance plateau despite steadily increasing training volume and, in her words, "eating pretty healthily." Walking through this chapter's full model: her menstrual irregularity is a significant warning sign, not a neutral side effect (Lesson 10.9), plausibly reflecting low energy availability given her described eating pattern relative to her substantial training volume; her stress fracture is consistent with the impaired bone density RED-S produces, itself reflecting reduced oestrogen's withdrawn bone-protective effect (Lesson 10.2); and her performance plateau, rather than reflecting insufficient training, is consistent with RED-S's well-documented tendency to impair rather than enhance performance despite high training volume (Lesson 10.9). "Eating pretty healthily" in a general sense does not rule out inadequate energy availability specifically relative to her exceptional training volume — the appropriate response is recommending increased energy availability and referral for medical evaluation of her menstrual and bone-health status, not further training volume increases or a tighter diet, precisely the counterintuitive-but-mechanistically-clear conclusion this chapter's model makes possible.

5Evidence-Based Practice, Revisited One Final Time

Lesson 10.10's myth-correction material closes this chapter, and this volume's broader hormonal-systems arc, on the same note established repeatedly across Chapters 7 through 9: genuine, well-documented physiological mechanisms exist throughout this material, and nutrition, sleep and training genuinely influence hormonal function within the normal range — but popular marketing routinely overstates what any single product or intervention can achieve beyond these established, unglamorous fundamentals. A nutrition professional's credibility and practical effectiveness depend on knowing precisely where that line falls, chapter after chapter, hormone after hormone.

Assessment and Case Studies

Learning Goal: Demonstrate integrated command of reproductive and growth hormone physiology through recall, explanation and applied reasoning.

AMultiple Choice

1Three Indian hormone cases

Priya, 26, Bengaluru, software engineer. Periods absent for seven months, training six days a week, eating around 1,300 kcal to “get lean”. This was low energy availability, not PCOS, and she was referred to a doctor before any nutrition plan was written. Intake was raised deliberately over three months with carbohydrate restored around training; periods returned in the fourth. She was told directly that losing periods is never a training achievement. Rohit, 33, Indore. Bought a testosterone booster and shilajit after reading that vegetarian diets suppress testosterone.

His actual problem was five hours of sleep, 55 g of protein a day and an eighteen-month continuous deficit. Soya, curd and paneer went into every meal, the deficit ended, sleep was protected, and the supplements were stopped. Kavya, 29, Kochi, diagnosed PCOS. Arrived with a list of teas and detox protocols from social media. Work focused on the one mechanism that responds — insulin sensitivity — through resistance training, a moderate deficit, adequate protein and sleep, with her gynaecologist managing diagnosis and medication. Cycles became more regular over five months.

BShort Answer

CApplied Case Studies

DProfessional Judgement